KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - NetShort-Term Debt repayments
Ratios

Pfizer (PFE) Other Gross PP&E Adjustments (2016 - 2025)

Pfizer (PFE) has disclosed Other Gross PP&E Adjustments for 17 consecutive years, with $34.5 billion as the latest value for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments rose 5.84% to $34.5 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $34.5 billion through Dec 2025, up 5.84% year-over-year, with the annual reading at $34.5 billion for FY2025, 5.84% up from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was $34.5 billion at Pfizer, up from $32.6 billion in the prior quarter.
  • The five-year high for Other Gross PP&E Adjustments was $34.5 billion in Q4 2025, with the low at $27.1 billion in Q4 2021.
  • Average Other Gross PP&E Adjustments over 5 years is $30.9 billion, with a median of $32.1 billion recorded in 2023.
  • The sharpest move saw Other Gross PP&E Adjustments rose 0.36% in 2021, then increased 12.71% in 2023.
  • Over 5 years, Other Gross PP&E Adjustments stood at $27.1 billion in 2021, then rose by 4.9% to $28.4 billion in 2022, then increased by 12.71% to $32.1 billion in 2023, then rose by 1.64% to $32.6 billion in 2024, then grew by 5.84% to $34.5 billion in 2025.
  • According to Business Quant data, Other Gross PP&E Adjustments over the past three periods came in at $34.5 billion, $32.6 billion, and $32.1 billion for Q4 2025, Q4 2024, and Q4 2023 respectively.